Close
  Indian J Med Microbiol
 

Figure 1: Maximal intensity projection (a) of staging whole-body fluorodeoxyglucose positron emission tomography/computed tomography scan. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal-fused positron emission tomography/computed tomography (b-d) images showing fluorodeoxyglucose-avid intraluminal mass lesion in anorectum region. MIP (e) of follow-up positron emission tomography/computed tomography scan after 6 months. Fused positron emission tomography/computed tomography axial and sagittal views (e-h) suggestive of an absence of fluorodeoxyglucose-avid visible mitotic disease. Maximal intensity projection (i) of positron emission tomography/computed tomography scan done 10 months after staging. Fused positron emission tomography/computed tomography axial and sagittal images (j-l) suggestive of recurrence with fluorodeoxyglucose-avid metastatic lesions in the liver, abdominal deposits, and fluorodeoxyglucose-avid skeletal lesion

Figure 1: Maximal intensity projection (a) of staging whole-body fluorodeoxyglucose positron emission tomography/computed tomography scan. Axial computed tomography, fused positron emission tomography/computed tomography, and sagittal-fused positron emission tomography/computed tomography (b-d) images showing fluorodeoxyglucose-avid intraluminal mass lesion in anorectum region. MIP (e) of follow-up positron emission tomography/computed tomography scan after 6 months. Fused positron emission tomography/computed tomography axial and sagittal views (e-h) suggestive of an absence of fluorodeoxyglucose-avid visible mitotic disease. Maximal intensity projection (i) of positron emission tomography/computed tomography scan done 10 months after staging. Fused positron emission tomography/computed tomography axial and sagittal images (j-l) suggestive of recurrence with fluorodeoxyglucose-avid metastatic lesions in the liver, abdominal deposits, and fluorodeoxyglucose-avid skeletal lesion